Concepedia

Michelle Priess

MP

Statistics

Publications

3

Citations

113

H-Index

3

Active since

2018

Affiliations

Sanofi (United States)(Current)

Michelle Priess is an author at Sanofi (United States) specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2018–2023

3

Publications

3

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody

Jessica D. Weaver, Edward C. Stack, Joshua Buggé et al. · OncoImmunology · 2022 · 58 citations · Full text

, , +17

Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors

Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith et al. · Molecular Cancer Therapeutics · 2023 · 34 citations

, , +17

Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer

Amanda MacDonald, Michelle Priess, Jennifer Curran et al. · Molecular Cancer Therapeutics · 2018 · 21 citations · Full text

, , +17

1–3 of 3